Robbins Andrew R bought COGT
December 17, 2025 · Form 4 insider transaction
Robbins Andrew R bought 185,000 shares of Cogent Biosciences, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
185,000
Price
$0.00
Total value
N/A
InsiderRobbins Andrew R
RoleOfficer, Director
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateDecember 17, 2025
Filing dateDecember 19, 2025
Shares owned after185,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Award of Restricted Stock Units ("RSUs") under the Issuer's 2018 Stock Option and Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date, subject to the Reporting Person's continuing service with the Issuer through such dates.